NCT03881215 is a NA clinical trial of Platelet Rich Plasma in Intra-uterine Adhesions, sponsored by Ain Shams University.

Who is sponsoring NCT03881215?

NCT03881215 is sponsored by Ain Shams University.

What drugs are being tested in NCT03881215?

Interventions in NCT03881215: Platelet Rich Plasma, intra-uterine balloon.

What condition does NCT03881215 study?

NCT03881215 studies Intra-uterine Adhesions.

Is NCT03881215 still recruiting?

NCT03881215 is currently completed. Last updated 28 January 2020.

Last reviewed 2020-01-28 · How we verify

NCT03881215

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Platelet Rich Plasma Following Hysteroscopic Adhesolysis

Completed NA Last updated 28 January 2020

What this trial tests

NA trial testing Platelet Rich Plasma in Intra-uterine Adhesions in 160 participants. Completed in 10 January 2020.

Timeline

1 January 2016

Primary endpoint
10 December 2019

10 January 2020

Quick facts

Lead sponsor	Ain Shams University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	160
Start date	1 January 2016
Primary completion	10 December 2019
Estimated completion	10 January 2020
Sites	1 location across Egypt

Drugs / interventions tested

Platelet Rich Plasma — full drug profile →
intra-uterine balloon

Conditions studied

Intra-uterine Adhesions — all drugs for Intra-uterine Adhesions →

Sponsor

Ain Shams University

Who can join

Adults 18 to 40, female only, with Intra-uterine Adhesions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Platelet Rich Plasma Following Hysteroscopic Adhesolysis: A Randomized Clinical Trial

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Therapeutic roles of platelet-rich plasma to restore female reproductive and endocrine dysfunction.
Wang X, Li J, Lu W, Gao F, et al · · 2024 · cited 8× · PMID 38654928 · DOI 10.3389/fendo.2024.1374382

Verify or expand the search:

Other trials of Platelet Rich Plasma

Trials testing the same drug.

NCT07483320 — Extracorporeal Shockwave Therapy and Platelet-Rich Plasma for Midportion Achilles Tendinopathy · NA · not yet recruiting
NCT07329361 — Efficacy and Safety of Intra-articular Injections of Frozen Platelet-Rich Plasma in Patients With Knee Osteoarthritis · NA · recruiting
NCT05224726 — Platelet Rich Plasma for Uterine Scar · NA · recruiting
NCT06810726 — Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroisc · Phase 2 · recruiting
NCT06769074 — Assessment of Platelet Rich Plasma Injection in Managing Female Patients Complaining of Mixed Urinary Incontinence (PRP) · NA · active not recruiting

Other Ain Shams University trials

Trials by the same sponsor.

NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03881215 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
Last refreshed: 28 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03881215.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing